FDA.reportPublic FDA data

Mepsevii 10 MG in 5 ML Injection

RxCUI
1989828
RxNorm name
Mepsevii 10 MG in 5 ML Injection
Display name
Mepsevii 10 MG in 5 ML Injection
Full name
Mepsevii 10 MG in 5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761047Mepseviivestronidase alfa-vjbk351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
925d4e21-fd98-474d-a34d-a0b3558ed750Mepsevii 10 MG in 5 ML Injection [PSN] · 5 ML vestronidase alfa-vjbk 2 MG/ML Injection [Mepsevii] [SBD] · 5 ML Mepsevii 2 MG/ML Injection [SY] · Mepsevii 10 MG per 5 ML Injection [SY]417These highlights do not include all the information needed to use MEPSEVII safely and effectively. See full prescribing information for MEPSEVII . MEPSEVII ® ( vestronidase alfa - vjbk ) injection , for intravenous use Initial U.S. Approval: 201720251118